menu search

Neuronetics: numerous expansion opportunities mean an outperforming stock

The high prevalence of major depressive disorder creates the need for Neuronetics' neurostar Advanced T...

November 28, 2022, 2:07 pm

Neuronetics to present at the piper sandler 34th annual healthcare conference

MALVERN, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, ...

November 21, 2022, 4:30 pm

Neuronetics announces neurostar® advanced therapy for mental health system innovations

Enhancements further establish the Company’s leadership position as the top transcranial magnetic stimulation therapy MALVERN, Pa., Nov. 14, 2022 (G...

November 14, 2022, 1:33 pm

Read why neuronetics shares are trading higher today

The FDA has cleared Neuronetics Inc's (NASDAQ: STIM) neurostar Advanced Therapy for Mental Health �...

July 19, 2022, 8:00 am

Neuronetics posts better than expected q4 results despite lower neurostar therapy system sales

Neuronetics Inc (NASDAQ: STIM) reported Q4 FY21 sales of $15.02 million, down 4% Y/Y, exceeding previously issued guidance of $13.0 million - $14.0 ...

March 8, 2022, 3:16 pm


Search within

Pages Search Results: